tiprankstipranks
Advertisement
Advertisement

GB:AZN Stock Latest News

AstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market
Company AnnouncementsAstraZeneca’s EMBOLD-Asia Trial Signals Fresh Push Into Obesity Market
5h ago
AZN
AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors
PremiumCompany Announcements
AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors
5h ago
AZN
AstraZeneca Expands Respiratory Pipeline With New China Trial for Chronic Lung Infections
PremiumCompany Announcements
AstraZeneca Expands Respiratory Pipeline With New China Trial for Chronic Lung Infections
1d ago
AZN
AstraZeneca CFO Receives First Vesting Under Long-Term Performance Share Plan
PremiumCompany Announcements
AstraZeneca CFO Receives First Vesting Under Long-Term Performance Share Plan
1d ago
AZN
AstraZeneca Tracks Real‑World Ultomiris Outcomes in Polish Rare Disease Study
PremiumCompany Announcements
AstraZeneca Tracks Real‑World Ultomiris Outcomes in Polish Rare Disease Study
2d ago
AZN
AstraZeneca to discontinue eVOLVE-Lung02 Phase III trial
PremiumThe FlyAstraZeneca to discontinue eVOLVE-Lung02 Phase III trial
3d ago
AZN
AstraZeneca announces results from DESTINY-Lung04 trial of Enhertu
Premium
The Fly
AstraZeneca announces results from DESTINY-Lung04 trial of Enhertu
3d ago
AZN
AstraZeneca announces results from Phase III trial of Tagrisso, savolitinib
Premium
The Fly
AstraZeneca announces results from Phase III trial of Tagrisso, savolitinib
3d ago
AZN
Mineralys Therapeutics price target lowered to $49 from $51 at BofA
PremiumThe Fly
Mineralys Therapeutics price target lowered to $49 from $51 at BofA
4d ago
AZN
MLYS
AstraZeneca: Volrustomig Setback Offset by Oncology Pipeline Strength; Buy Rating and 16,500 GBp Price Target Maintained
PremiumRatings
AstraZeneca: Volrustomig Setback Offset by Oncology Pipeline Strength; Buy Rating and 16,500 GBp Price Target Maintained
4d ago
AZN
AstraZeneca’s Enhertu tops standard care in first-line HER2-mutant lung cancer trial
PremiumCompany Announcements
AstraZeneca’s Enhertu tops standard care in first-line HER2-mutant lung cancer trial
4d ago
AZN
AstraZeneca Halts Key Lung Cancer Trial of Volrustomig After Missed Efficacy Goals
PremiumCompany Announcements
AstraZeneca Halts Key Lung Cancer Trial of Volrustomig After Missed Efficacy Goals
4d ago
AZN
AstraZeneca’s Tagrisso–Orpathys Combo Delivers Phase III Survival Gains in MET-Driven Lung Cancer
PremiumCompany AnnouncementsAstraZeneca’s Tagrisso–Orpathys Combo Delivers Phase III Survival Gains in MET-Driven Lung Cancer
4d ago
AZN
AstraZeneca Targets Indian Lung Cancer Market With New Imfinzi Safety Study
Premium
Company Announcements
AstraZeneca Targets Indian Lung Cancer Market With New Imfinzi Safety Study
8d ago
AZN
Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports
Premium
The Fly
Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports
9d ago
AZN
BMY
Trump Trade: President signs EO to split up of childhood vaccines
PremiumThe Fly
Trump Trade: President signs EO to split up of childhood vaccines
9d ago
AZN
EBS
Trump signs EO to split up of childhood vaccines, Bloomberg reports
PremiumThe Fly
Trump signs EO to split up of childhood vaccines, Bloomberg reports
10d ago
AZN
EBS
Trump Trade: U.S. issues 15% duty on products made from polysilicon
PremiumThe Fly
Trump Trade: U.S. issues 15% duty on products made from polysilicon
13d ago
AZN
EBS
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
PremiumThe Fly
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
13d ago
AZN
EBS
AstraZeneca: Buy Rating Reiterated on Attractive Valuation, Robust Pipeline, and Unchanged $16,500 Price Target
PremiumRatingsAstraZeneca: Buy Rating Reiterated on Attractive Valuation, Robust Pipeline, and Unchanged $16,500 Price Target
13d ago
AZN
Unusually active option classes on open August 5th
Premium
The Fly
Unusually active option classes on open August 5th
15d ago
AZN
DIS
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
Premium
The Fly
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
15d ago
AZN
BBY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >